IL-1- and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase

Journal of Cellular Physiology

Volumn 187, Issue 3, 2001, Pages 294-303

  Kumar, Sanjay ^a,b   Votta, Bartholomew J ^a   Rieman, David J ^a   Badger, Alison M ^a   Gowen, Maxine ^a   Lee, John C ^a  

^a GLAXOSMITHKLINE   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CALCITRIOL; INTERLEUKIN 1; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; PARATHYROID HORMONE; SOMATOMEDIN B; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CATTLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL ASSAY; BONE RESORPTION; CALCIUM RADIOISOTOPES; CATTLE; CELLS, CULTURED; CHONDROCYTES; CULTURE TECHNIQUES; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; GROWTH SUBSTANCES; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; MITOGEN-ACTIVATED PROTEIN KINASES; OSTEOBLASTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RADIUS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; ULNA;

BOVINAE;

EID: 0035040946     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.1082     Document Type: Article

References (52)

1. Interleukin-6 does not stimulate bone resorption in neonatal mouse calvariae
2. Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency
3. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resporption, endotoxin shock and immune function
4. SB 203580 inhibits p38 mitogen-activated proein kinase, nitric oxide production, and inducible nitric oxide synthase in bovine cartilage-derived chondrocytes
5. Differential effects of SB 242235, a selective p38 mitogen-activated protein kinase inhibitor, on IL-1 treated bovine and human cartilage/chondrocyte cultures
6. 3, parathyroid hormone, and glucocorticoids
7. Interleukin 6 production in fetal rat long bone cultures is correlated with PGE2 release and does not correlate with the extent of bone resorption
8. Signal transduction via the MAP kinases: Proceed at your own RISK
9. Activation of extracellular signal-regulated kinases 1 and 2 (ERK1 and ERK2) by FGF-2 and PDGF-BB in normal human osteoblastic and bone marrow stromal cells - Differences in mobility and in-gel renaturation of erkl in human, rat, and mouse osteoblastic cells
10. How MAP kinases are regulated
11. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1
12. Pyrroles and other heterocycles as inhibitors of p38 kinase
13. Activation of osteoclasts by interleukin-1: Divergent responsiveness in osteoclasts formed in vivo and in vitro
14. Interleukin-6 and its soluble receptor cause a marked induction of collagenase 3 expression in rat osteoblast cultures
15. Selective activation of the mitogen-activated protein kinase subgroups c-Jun NH2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes
16. Interleukin-1-beta-modulated gene expression in immortalized human chondrocytes
17. IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro
18. Regulation of interleukin-6 expression in human osteoblastic cells in vitro
19. IL-6 is produced by osteoblasts and induces bone resorption
20. Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats
21. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice
22. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction
23. Osteoprotegerin ligand: A regulator of immune responses and bone physiology
24. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation
25. MAPKAP Kinase 2 is essential for LPS-induced TNF-a biosynthesis
26. Involvement of p38 mitogen-activated protein kinase in basic fibroblast growth factor-induced interleukin-6 synthesis in osteoblasts
27. Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase
28. IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release
29. Modulation of actin dynamics during stress and physiological stimulation by a signaling pathway involving p38 map kinase and heat-shock protein 27
30. Bicyclic imidazoles as a novel class of cytokine biosynthesis inhibitors
31. p38 mitogen-activated protein kinase inhibitors-Mechanism and therapeutic potentials
32. Inhibition of p38 MAP kinase as a therapeutic strategy
33. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
34. The modulation of the expression of IL-6 and its receptor in human osteoblasts in vitro
35. The role of cytokines in the regulation of local bone resorption
36. Mice lacking the type I interleukin-1 receptor do not lose bone mass after ovariectomy
37. Cytokines and bone
38. Role of cytokines in bone resorption
39. The role of interlukin-6 type cytokines and their receptors in bone
40. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
41. Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL)
42. Immunohistological analysis of cytokine expression in human osteoarthritic and healthy cartilage
43. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappa B ligand: Modulation of the expression by osteotropic factors and cytokines
44. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion
45. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine
46. Bone resorption in tissue culture
47. Interleukin-6; an osteotropic factor?
48. Organ culture of bone. Skeletal Researcher
49. The role of cytokines and growth factors in cartilage destruction in osteoarthritis and rheumatoid arthritis
50. Parathyroid hormone inhibits mitogen-activated protein kinase activation in osteosarcoma cells via a protein kinase a-dependent pathway
51. Parathyroid hormone activates mitogen-activated protein kinase via a camp-mediated pathway independent of Ras
52. Cytokine suppressive anti-inflammatory compounds inhibit bone resorption in vitro